Tailoring Smoking Cessation Treatment by Genotype:
Implications for
Ethics and Clinical Practice (RWJ TTURC)
Dr. Shields is currently a PI for a 5-year grant from
the Robert Wood Johnson Foundation to study clinical and ethical issues
related to tailoring smoking cessation treatment by genotype.